Class III antiarrhythmic agents like sotalol and amiodarone are effective for ventricular arrhythmias but have distinct, complex pharmacologic and side effect profiles that must be managed carefully.
No takes yet. Share an insight, caveat, or question.
May inform individualized class III agent selection in ventricular arrhythmias; leaves open optimal comparisons versus contemporary therapies in randomized trials.
Jerry L. Bauman (1997) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: